Therapy for dyskinesias in Parkinson’s disease patients

Author： Stefani Alessandro   Pierantozzi Mariangela   Koch Giacomo   Galati Salvatore   Stanzione Paolo  

Publisher： Future Medicine

ISSN： 1479-6708

Source： Future Neurology, Vol.5, Iss.2, 2010-03, pp. : 277-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased adenosine A 2A receptors in the brain of Parkinson’s disease patients with dyskinesias

By Calon Frédéric  

Brain, Vol. 127, Iss. 5, 2004-05 ,pp. : 1075-1084

Oxford University Press

Access to resources Recommend Favorite

The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson’s disease

By Lemieux Sarah   Ghassemi Mehrdad   Jog Mandar   Edwards Roderick   Duval Christian  

Experimental Brain Research, Vol. 176, Iss. 3, 2007-01 ,pp. : 465-475

Springer Publishing Company

Access to resources Recommend Favorite

Force overflow and levodopa-induced dyskinesias in Parkinson’s disease

By Wenzelburger R.   Zhang B-R.   Pohle S.   Klebe S.   Lorenz D.   Herzog J.   Wilms H.   Deuschl G.   Krack P.  

Brain, Vol. 125, Iss. 4, 2002-04 ,pp. : 871-879

Oxford University Press

Access to resources Recommend Favorite

Pathological gambling in two patients on dopamine replacement therapy for Parkinson’s disease

By Avanzi M.   Uber E.   Bonfà F.  

Neurological Sciences, Vol. 25, Iss. 2, 2004-06 ,pp. : 98-101

Springer Publishing Company

Access to resources Recommend Favorite

Apathy in patients with Parkinson’s disease

By Shulman Lisa M.  

International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. : 298-306

Informa Healthcare

Access to resources Recommend Favorite